IFN beta 1 (Middle Region) Antikörper
-
- Target
- IFN beta 1
- Bindungsspezifität
- Middle Region
- Reaktivität
- Human
- Wirt
- Kaninchen
- Klonalität
- Polyklonal
- Applikation
- Western Blotting (WB)
- Spezifität
- IFN Beta 1 antibody was raised against the middle region of IFNB1
- Aufreinigung
- Affinity purified
- Immunogen
- IFN Beta 1 antibody was raised using the middle region of IFNB1 corresponding to a region with amino acids NLLANVYHQINHLKTVLEEKLEKEDFTRGKLMSSLHLKRYYGRILHYLKA
-
- Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. - Kommentare
-
IFN Beta 1 Blocking Peptide, catalog no. 33R-6764, is also available for use as a blocking control in assays to test for specificity of this IFN Beta 1 antibody
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of IFNB1 antibody in PBS
- Konzentration
- Lot specific
- Buffer
- PBS
- Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
The reduction of voluntary physical activity after poly I:C injection is independent of the effect of poly I:C-induced interferon-beta in mice." in: Physiology & behavior, Vol. 93, Issue 4-5, pp. 835-41, (2008) (PubMed).
: "
-
The reduction of voluntary physical activity after poly I:C injection is independent of the effect of poly I:C-induced interferon-beta in mice." in: Physiology & behavior, Vol. 93, Issue 4-5, pp. 835-41, (2008) (PubMed).
-
- Target
- IFN beta 1
- Hintergrund
- IFNB1 has antiviral, antibacterial and anticancer activities.
- Molekulargewicht
- 22 kDa (MW of target protein)
-